The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes. New research reveals ways that antibodies can recognize these different shapes and block the virus and informs the design of vaccines and antiviral therapies.

As people get older, their neural stem cells lose the ability to proliferate and produce new neurons, leading to a decline in memory function. Researchers have now discovered a mechanism linked to stem cell aging and how the production of neurons can be reactivated.

Researchers are using stem cell-derived organoids to study how SARS-CoV-2 interacts with various organ systems and to develop therapies to block infection.

What makes one coronavirus more infectious than the other? The lab of or Dr Mahmoud Moradi at the University of Arkansas has used molecular simulations, performed at the Texas Advanced Computing Center and the Pittsburgh Supercomputing Center, to investigate this question.

At Technology Networks we understand the importance of time. That's why we've launched Teach Me in 10 a video series that challenges scientists to present and summarize their research area, a scientific concept, or technology in ten minutes or less.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

In this article, we explore recent developments in antibody screening that can quickly identify and prioritize antibodies for further development.

In this article, we bring together resources from the across the site on gas chromatography, how it works, its pairing with downstream techniques and what its applications are.

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.